Pulmonary surfactant and inflammation in septic adult mice: Role of surfactant protein A

Journal of Applied Physiology

Volumn 92, Issue 2, 2002, Pages 809-816

  Malloy, Jaret L ^a   Veldhuizen, Ruud A W ^b   McCormack, Francis X ^c   Korfhagen, Thomas R ^a   Whitsett, Jeffery A ^b   Lewis, James F ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cecal ligation and perforation; Cytokines; In vivo; Mouse; Surfactant aggregates

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LUNG SURFACTANT; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE DURATION; FEMALE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; TISSUE LEVEL;

EID: 0036095326     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00628.2001     Document Type: Article

References (36)

1. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant
2. Immunosuppressive activity of canine pulmonary surface active material
3. Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription
4. A rapid method of total lipid extraction and purification
5. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo
6. Ventilation with lower tidal volumes compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
7. Surfactant proteins A and D and pulmonary host defense
8. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate
9. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A
10. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin
11. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock
12. The pulmonary collectins and surfactant metabolism
13. Tolerance of SP-A-deficient mice to hyperoxia or exercise
14. Surfactant metabolism in surfactant protein A-deficient mice
15. Characteristics of surfactant from SP-A-deficient mice
16. IL-4 increases surfactant and regulates metabolism in vivo
17. Altered surfactant function and structure in SP-A gene targeted mice
18. Cleavage of structural proteins during assembly of the head of bacterial T4
19. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
20. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice
21. Altered surfactant function and metabolism in rabbits with acute lung injury
22. Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep
23. Protein measurement with the Folin reagent
24. Alterations of the endogenous surfactant system in septic adult rats
25. Effects of ventilation on the surfactant system in sepsis-induced lung injury
26. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time
27. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
28. Surfactant treatments alter endogenous surfactant metabolism in rabbit lungs
29. Tumor necrosis factor-α decreases surfactant protein B mRNA in murine lung
30. Regulation of surfactant proteins A and B by TNF-α and phorbol ester independent of NF-κB
31. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after early onset of systemic inflammatory response syndrome or sepsis
32. Effects of intratracheal instillation of TNF-α on surfactant metabolism
33. Intratracheal aerosolization of endotoxin (LPS) in the rat: A comprehensive animal model to study adult (acute) respiratory distress syndrome
34. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes
35. Interleukin-6-induced protection in hyperoxic acute lung injury
36. Regulation of pulmonary surfactant secretion and clearance